FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox
Emergent BioSolutions’ smallpox vaccine, ACAM2000, now has an additional FDA approval covering mpox. It’s one of two FDA-approved mpox vaccines, joining Jynneos from Bavarian Nordic.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
